The team of the Executive Board shapes the future of LTS as market leader for transdermal innovative solutions.
Some of the most important tasks of the LTS Executive Board are the development of corporate strategy, the fixing of the company budged as well as the allocation of resources. It informs the Supervisory Board on a regular basis in a timely and comprehensive manner about all questions relevant to LTS AG, e.g., planning, corporate development, risk analyses and risk management.

H. Werner Lüscher

Chief Financial Officer, Executive Board Member

  • More than 20 years of experience in industry and consultancy in a variety of management positions
  • Joined LTS in 2000, Member of the Executive Board LTS AG since 2008

B. Michael Hoffmann

Chief TechOps Officer, Executive Board Member

  • Joined LTS at its very start in 1984. More than 25 years of experience in different leading positions

  • Member of the Executive Board since 2016.

Dr. Tim Schlange

Chief Market Officer, Executive Board Member

  • More than 20 years experience in Life Sciences and Specialty Chemicals in different businesses and management positions at Ciba-Geigy/Novartis, Ciba Spec. Chemicals and Lonza
  • Joined LTS in 2013, as a Member of the Executive Board

Ulrich Sielaff

Chief Legal & HR Officer, Executive Board Member

  • Joined LTS in 2002, several years of experience in different leading positions

  • Member of the Executive Board since 2017.